UPC Analytics
ENDE
Overview · Filed: —

UPC_APP_36985/2025

Methods of Using Sustained Release Aminopyridine Compositions

Procedural & sub-applicationsOther ProceduralParis LDGeneric application—
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Merz Therapeutics GmbH
  • Merz Pharmaceuticals LLC
  • Merz Pharma France
Reps: Laëtitia Bénard

Respondents

  • Viatris Santé
Reps: Marc Lauzeral
Judges

French-seated division — individual judges anonymized.

  • Panel member (anonymized)Presiding judge and judge-rapporteur
  • Panel member (anonymized)Legally qualified judge
  • Panel member (anonymized)Legally qualified judge
  • Panel member (anonymized)Technically qualified judge
Patents
  • EP 2 377 536
CPC codes: A61P43/00, A61P19/08, A61K31/435, A61P25/28, A61K9/20, A61K31/44, A61P21/00, A61P17/02, A61K31/4409, A61P25/00

Sector: Pharmaceutical & Medical

Outcome
Procedural only
Filed: —
First decided: Sep 17, 2025
Language: —